1. China Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 91
Price: Single User License – US$2500
China Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “China Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the China Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the China Diabetes Care
Devicesmarket.
- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Inc., Novo
Nordisk A/S, Abbott Laboratories, Becton, Dickinson and Company and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197485-china-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In China 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices Market, China, Revenue Mix ($m), 2011 12
3.4 Diabetes Care Devices Market, China, Category Contribution (%), 2011 13
3.5 Diabetes Care Devices, China, Company Share (2010-2011) 18
4 Glucose Monitoring In China 20
4.1 Glucose Monitoring, Market Segmentation 20
4.2 Glucose Monitoring Market, China, Revenue Mix ($m), 2011 21
4.3 Glucose Monitoring Market, China, Segment Contribution (%), 2011 22
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 23
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 27
4.5 Glucose Monitoring Overall Volume (2004-2018) 31
4.5.1 Blood Glucose Meters, Volume (2004-2018) 35
4.6 Glucose Monitoring Average Price (2004-2018) 38
4.7 Glucose Monitoring Distribution Share (2010-2011) 39
4.8 Glucose Monitoring, China, Company Share (2010-2011) 40
5 Insulin Delivery In China 42
5.1 Insulin Delivery, Market Segmentation 42
5.2 Insulin Delivery Market, China, Revenue Mix ($m), 2011 43

3. 5.3 Insulin Delivery Market, China, Segment Contribution (%), 2011 44
5.4 Insulin Delivery Overall Revenue, (2004-2018) 45
5.4.1 Insulin Pens, Revenue (2004-2018) 49
5.4.2 Insulin Pumps, Revenue (2004-2018) 53
5.5 Insulin Delivery Overall Volume (2004-2018) 55
5.5.1 Insulin Pens, Volume (2004-2018) 59
5.5.2 Insulin Pumps, Volume (2004-2018) 63
5.6 Insulin Delivery Average Price (2004-2018) 65
5.7 Insulin Delivery Distribution Share (2010-2011) 66
5.8 Insulin Delivery, China, Company Share (2010-2011) 67
6 Overview of Key Companies in China Diabetes Care Devices Market 69
6.1 LifeScan, Inc. 69
6.1.1 Company Overview 69
6.1.2 Share in the China Diabetes Care Devices Market 69
6.2 F. Hoffmann-La Roche Ltd. 70
6.2.1 Company Overview 70
6.2.2 Share in the China Diabetes Care Devices Market 70
6.3 Medtronic, Inc. 71
6.3.1 Company Overview 71
6.3.2 Share in the China Diabetes Care Devices Market 71
6.4 Novo Nordisk A/S 72
6.4.1 Company Overview 72
6.4.2 Share in the China Diabetes Care Devices Market 72
6.5 Abbott Laboratories 73
6.5.1 Company Overview 73
6.5.2 Share in the China Diabetes Care Devices Market 73
6.6 Becton, Dickinson and Company 74
6.6.1 Company Overview 74
6.6.2 Share in the China Diabetes Care Devices Market 74
6.7 ARKRAY, Inc. 75
6.7.1 Company Overview 75
6.8 Bayer HealthCare AG 75
6.8.1 Company Overview 75
6.9 Eli Lilly and Company 75
6.9.1 Company Overview 75
6.10 Sanofi 76
6.10.1 Company Overview 76
6.11 Animas Corporation 76
6.11.1 Company Overview 76
6.12 Terumo Corporation 76
6.12.1 Company Overview 76
7 Diabetes Care Devices Market Pipeline Products 77

4. 8 Financial Deals Landscape 80
8.1 Partnerships 80
8.1.1 Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 80
8.1.2 Insulet Expands Distribution Agreement With Ypsomed Holding 82
9 Recent Developments 83
9.1 Strategy And Business Planning 83
9.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 83
9.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 83
9.2 Research And Development 84
9.2.1 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug Discovery
Partnership 84
9.3 Legal and Regulatory 84
9.3.1 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For
Medical Devices 84
10 Appendix 86
10.1 Definitions of Markets Covered in the Report 87
10.1.1 Diabetes Care Devices 87
10.2 Research Methodology 89
10.3 Secondary Research 89
10.4 Primary Research 90
10.5 Models 90
10.6 Forecasts 90
10.7 Expert Panels 91
10.8 GlobalData Consulting 91
10.9 Currency Conversion 91
10.10 Contact Us 91
10.11 Disclaimer 91
1.1 List of Tables
Table 1: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 11
Table 2: Diabetes Care Devices Market, China, Category Contribution (%), 2011 13
Table 3: Diabetes Care Devices, China, Cross-Segment Analysis, 2004-2018 15
Table 4: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Table 5: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 17
Table 6: Diabetes Care Devices, China, Company Share by Revenue ($m), USD Constant, 2010-
2011 19
Table 7: Glucose Monitoring Market, China, Segment Contribution (%), 2011 22
Table 8: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 24
Table 9: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-

5. 2018 26
Table 10: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 28
Table 11: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 30
Table 12: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2004-2011 32
Table 13: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2011-2018 34
Table 14: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 35
Table 15: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 37
Table 16: Glucose Monitoring, China, Average Price ($), Historic, 2004-2011 38
Table 17: Glucose Monitoring, China, Average Price ($), Forecast, 2011-2018 38
Table 18: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 39
Table 19: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-
2011 41
Table 20: Insulin Delivery Market, China, Segment Contribution (%), 2011 44
Table 21: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
46
Table 22: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 48
Table 23: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 50
Table 24: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 52
Table 25: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,
Historic, 2004-2011 53
Table 26: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,
Forecast, 2011-2018 54
Table 27: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2004-2011 56
Table 28: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2011-2018 58
Table 29: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 60
Table 30: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62
Table 31: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Historic, 2004-2011
63
Table 32: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Forecast, 2011-2018
64
Table 33: Insulin Delivery, China, Average Price ($), Historic, 2004-2011 65
Table 34: Insulin Delivery, China, Average Price ($), Forecast, 2011-2018 65
Table 35: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
66
Table 36: Insulin Delivery, China, Company Share by Revenue ($m), USD Constant, 2010-2011
68

6. Table 37: Diabetes Care Devices Market Pipeline Products 77
Table 38: Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 80
Table 39: Insulet Expands Distribution Agreement With Ypsomed Holding 82
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices Market, China, Revenue Mix ($m), 2011 12
Figure 4: Diabetes Care Devices Market, China, Category Contribution (%), 2011 13
Figure 5: Diabetes Care Devices, China, Cross-Segment Analysis, 2004-2018 14
Figure 6: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Figure 7: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 17
Figure 8: Diabetes Care Devices, China, Company Share (%)-2011 18
Figure 9: Glucose Monitoring, Market Segmentation 20
Figure 10: Glucose Monitoring Market, China, Revenue Mix ($m), 2011 21
Figure 11: Glucose Monitoring Market, China, Segment Contribution (%), 2011 22
Figure 12: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 23
Figure 13: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 25
Figure 14: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 27
Figure 15: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 29
Figure 16: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2004-2011 31
Figure 17: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2011-2018 33
Figure 18: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 35
Figure 19: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018
36
Figure 20: Glucose Monitoring, China, Company Share (%), 2011 40
Figure 21: Insulin Delivery, Market Segmentation 42
Figure 22: Insulin Delivery Market, China, Revenue Mix ($m), 2011 43
Figure 23: Insulin Delivery Market, China, Segment Contribution (%), 2011 44
Figure 24: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
45
Figure 25: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 47
Figure 26: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 49
Figure 27: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-

7. 2018 51
Figure 28: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,
Historic, 2004-2011 53
Figure 29: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,
Forecast, 2011-2018 54
Figure 30: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2004-2011 55
Figure 31: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2011-2018 57
Figure 32: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 59
Figure 33: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 61
Figure 34: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Historic, 2004-2011
63
Figure 35: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Forecast, 2011-2018
64
Figure 36: Insulin Delivery, China, Company Share (%), 2011 67
Figure 37: LifeScan, Inc., Company Share (%),China Diabetes Care Devices Market, 2011 69
Figure 38: F. Hoffmann-La Roche Ltd., Company Share (%),China Diabetes Care Devices Market,
2011 70
Figure 39: Medtronic, Inc., Company Share (%),China Diabetes Care Devices Market, 2011 71
Figure 40: Novo Nordisk A/S, Company Share (%),China Diabetes Care Devices Market, 2011 72
Figure 41: Abbott Laboratories, Company Share (%),China Diabetes Care Devices Market, 2011
73
Figure 42: Becton, Dickinson and Company, Company Share (%),China Diabetes Care Devices
Market, 2011 74
Contact: sales@reportsandreports.com for more information.